Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment practices and lipid profile of patients with acute coronary syndrome: results from a tertiary care hospital.
Farmakis I, Zafeiropoulos S, Kartas A, Boulmpou A, Nevras V, Papadimitriou I, Tampaki A, Vlachou A, Markidis E, Koutsakis A, Ziakas A, Karvounis H, Giannakoulas G. Farmakis I, et al. Among authors: vlachou a. Acta Cardiol. 2020 Oct;75(6):527-534. doi: 10.1080/00015385.2019.1626087. Epub 2019 Jun 20. Acta Cardiol. 2020. PMID: 31219734 Clinical Trial.
Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design.
Boulmpou A, Kartas A, Farmakis I, Zafeiropoulos S, Nevras V, Papadimitriou I, Tampaki A, Vlachou A, Lillis L, Koutsakis A, Karvounis H, Giannakoulas G. Boulmpou A, et al. Among authors: vlachou a. Hellenic J Cardiol. 2019 Jul-Aug;60(4):249-253. doi: 10.1016/j.hjc.2018.10.002. Epub 2018 Oct 21. Hellenic J Cardiol. 2019. PMID: 30352291 Free article. Clinical Trial.
Reinforcing adherence to lipid-lowering therapy after an acute coronary syndrome: A pragmatic randomized controlled trial.
Zafeiropoulos S, Farmakis I, Kartas A, Arvanitaki A, Pagiantza A, Boulmpou A, Tampaki A, Kosmidis D, Nevras V, Markidis E, Papadimitriou I, Vlachou A, Arvanitakis K, Miyara SJ, Ziakas A, Molmenti EP, Kassimis G, Zanos S, Karvounis H, Giannakoulas G. Zafeiropoulos S, et al. Among authors: vlachou a. Atherosclerosis. 2021 Apr;323:37-43. doi: 10.1016/j.atherosclerosis.2021.03.013. Epub 2021 Mar 17. Atherosclerosis. 2021. PMID: 33780749 Clinical Trial.
Policy Guidelines for Effective Inclusion and Reintegration of People with Chronic Diseases in the Workplace: National and European Perspectives.
Vlachou A, Stavroussi P, Roka O, Vasilou E, Papadimitriou D, Scaratti C, Kadyrbaeva A, Fheodoroff K, Brecelj V, Svestkova O, Tobiasz-Adamczyk B, Finnvold JE, Gruber S, Leonardi M. Vlachou A, et al. Int J Environ Res Public Health. 2018 Mar 11;15(3):493. doi: 10.3390/ijerph15030493. Int J Environ Res Public Health. 2018. PMID: 29534484 Free PMC article.
Effectiveness of Integration and Re-Integration into Work Strategies for Persons with Chronic Conditions: A Systematic Review of European Strategies.
Sabariego C, Coenen M, Ito E, Fheodoroff K, Scaratti C, Leonardi M, Vlachou A, Stavroussi P, Brecelj V, Kovačič DS, Esteban E. Sabariego C, et al. Among authors: vlachou a. Int J Environ Res Public Health. 2018 Mar 19;15(3):552. doi: 10.3390/ijerph15030552. Int J Environ Res Public Health. 2018. PMID: 29562715 Free PMC article. Review.
Identifying the Employment Needs of People With Chronic Health Conditions in Europe.
Ávila CC, Ayuso-Mateos JL, Muñoz-Murillo A, Scaratti C, Coenen M, Vlachou A, Fheodoroff K, Pilat A, Tabaj A, Svestkova O, Kadyrbaeva A, Cabello M. Ávila CC, et al. Among authors: vlachou a. J Occup Environ Med. 2018 Nov;60(11):e618-e624. doi: 10.1097/JOM.0000000000001425. J Occup Environ Med. 2018. PMID: 30095532
58 results